585 Shares in Kewaunee Scientific Co. (NASDAQ:KEQU) Purchased by IFP Advisors Inc

IFP Advisors Inc acquired a new position in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 585 shares of the technology company’s stock, valued at approximately $36,000.

Other hedge funds have also modified their holdings of the company. De Lisle Partners LLP grew its stake in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares in the last quarter. State Street Corp bought a new position in Kewaunee Scientific in the third quarter valued at approximately $266,000. Janney Montgomery Scott LLC bought a new position in Kewaunee Scientific in the fourth quarter valued at approximately $338,000. Barclays PLC bought a new position in Kewaunee Scientific in the third quarter valued at approximately $121,000. Finally, Geode Capital Management LLC grew its stake in Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors.

Insider Activity

In related news, VP Douglas J. Batdorff sold 3,470 shares of Kewaunee Scientific stock in a transaction that occurred on Monday, December 30th. The stock was sold at an average price of $65.50, for a total transaction of $227,285.00. Following the completion of the sale, the vice president now directly owns 5,000 shares of the company’s stock, valued at approximately $327,500. This trade represents a 40.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $63.01, for a total value of $126,020.00. Following the sale, the chief executive officer now directly owns 42,497 shares of the company’s stock, valued at approximately $2,677,735.97. The trade was a 4.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,994 shares of company stock valued at $729,430 over the last three months. Insiders own 14.20% of the company’s stock.

Kewaunee Scientific Stock Performance

KEQU opened at $49.38 on Friday. Kewaunee Scientific Co. has a 12-month low of $27.00 and a 12-month high of $71.33. The stock has a market cap of $141.82 million, a price-to-earnings ratio of 7.83 and a beta of 0.71. The business has a 50 day moving average of $60.39 and a 200-day moving average of $48.08. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings data on Wednesday, December 11th. The technology company reported $1.41 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.